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Abstract
Background: Preferred methods of contraception vary from country to country. Family Planning services have been
available on a large scale in Ghana since the 1980’s and their use has contributed to gradual decline in the total fertility
rate from 6.4 in 1988 to 4.2 in 2014. Since their introduction in Ghana in the early 1990’s, Injectable contraceptives have
seen increasing patronage and are currently the most preferred method of contraception. We set out to identify
possible factors contributing to the preference for injectable contraceptives among women in Ghana.
Methods: We conducted a descriptive cross-sectional survey of women accessing contraceptive services at the Family
Planning Unit of the Komfo Anokye Teaching Hospital in Kumasi, Ghana. Women who reported for the second dose of
their injections were eligible to be selected for participation in the study. Informed consent was obtained from eligible
participants. Data was collected using a structured questionnaire in January and February 2011. Data captured included
age, marital status, highest level of education completed, religion, ethnicity and employment status, previous
contraceptive use, sources of contraceptive information and reasons for choosing injectable contraceptives.
Quantitative data was entered into a Microsoft Access Database and analysed using Epi Info Version 7.1.4.
Qualitative data was analysed thematically.
Results: A total of 247 respondents participated in the study. One hundred and seventy three (70.0 %) were using Depot
Medroxyprogesterone Acetate and 74 (30.0 %) were using NorethisteroneEnanthate/Estradiol Valerate. The mean age for
women on Depot Medroxyprogesterone Acetate was higher than those on NorethisteroneEnanthate/Estradiol Valerate
(p < 0.001). The effectiveness of method, recommendation from other users, low incidence of forgetfulness and
the relatively longer intervals for administration were the commonest reasons for the use of injectables among
respondents. The majority of users, 225 (91.1 %), were satisfied with the method and will recommend it to other
potential users. Only 10.8 % of the 68 respondents reporting undesirable effects of the injectables intend to
change the method.
Conclusion: A high level of satisfaction exists among current users of injectables in Ghana and is influenced by a
variety of factors. Strategies to increase the uptake of injectables can go a long way to increase the contraceptive
prevalence rate and reduce the unmet need for Family Planning in Ghana.
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Background
Various methods of contraception are available globally and
various factors may influence the use. Although there is no
internationally recognized ‘ideal’ method mix, skewed uptake
of a contraceptive method may reflect local cultural prefer-
ences or social norms, but may become worrisome if it re-
sults from restrictive population policies, lack of access to a
broad range of methods, or provider bias [1]. The most pre-
ferred methods of contraception vary from country to coun-
try. In Nigeria, the Intrauterine Contraceptive Device (IUD),
male condoms and injectables have been identified as the
most patronised methods [2–4] while in Canada, Oral
Contraceptives, Condoms and Sterilisation have been
found to be the preferred methods [5] with Ethiopia
reporting Injectables as the most preferred method [6].
Various reasons underlie the preference of one method
over the other [7–11]. Understanding factors that drive
contraceptive method choice is important for policy for-
mulation and implementation for the provision of
methods that are accessible and acceptable to users [12].
Family Planning services have been available on a large
scale in Ghana since the 1980’s and their use has re-
sulted in a decline in Ghana’s fertility rate from 6.4 in
1988 to 4.2 in 2014 [13, 14]. Knowledge on contracep-
tion is almost universal in Ghana [13]. Among the various
contraceptives available in Ghana are two types of inject-
ables are available, a progestin-only injectable contracep-
tive, Depot Medroxyprogesterone Acetate (DMPA) given
once every three months and a combined-injectable
contraceptive (CIC), NorethisteroneEnanthate/Estradiol
Valerate (NET-EN/EV) given monthly [15]. Current and
prospective users identify injectables as the method of
choice [13, 14, 16] but the reasons for these have not been
explored. In the present study, we set out to describe the
characteristics of women on the two types of injectable
contraceptives available in Ghana and to identify possible
factors contributing to their preference.
Methods
This study was conducted at the Family Planning Unit of
the Komfo Anokye Teaching Hospital (KATH). KATH is
a 1,200-bed tertiary level referral centre providing both
basic and specialised services. The Family Planning Unit is
part of the Directorate of Obstetrics and Gynaecology.
The unit provides a wide array of contraceptive methods
including oral contraceptive pills, injectable contracep-
tives, intrauterine contraceptive devices, male and female
condoms and implants. The unit is also equipped with a
theatre where minor surgical procedures such as bilateral
tubal ligation and vasectomy are performed. Clients acces-
sing services at the unit are mostly from the Kumasi
metropolitan area.
This was a descriptive cross sectional study. The study
population was women accessing services at the Family
Planning Unit of the KATH. Women who reported for
the second or subsequent doses of injectable contracep-
tives were eligible to be recruited into the study. All eli-
gible women were approached for participation in the
study over a two-month period, January and February
2011. Potential respondents who agreed to participate
following receipt of information on the study were pro-
vided with a study information leaflet and informed con-
sent was obtained. Consecutive cases of eligible women
who gave consent were included in the study on their
respective clinic days. Women on injectables who did
not give informed consent or who had participated in
the previous month were excluded. Using single popula-
tion proportion formula for descriptive study (StatCal) a
sample size of 250 was determined with following as-
sumptions: 95 % confidence level, 75 % injectable contra-
ceptive users in KATH choose DMPA, confidence limit of
5 %, design effect of 1. This allowed a good representative
sample of DMPA and NET-EN/EV users to be included in
the study. A structured questionnaire consisting of both
open and close-ended questions was employed for data
collection. The variables studied included age, marital sta-
tus, highest level of education completed, religion, ethni-
city and employment status, contraceptive methods
previously used, sources of contraceptive information, rea-
sons for choosing injectable contraceptives and their expe-
riences using the method. The questionnaire was
administered by a trained Research Assistant. Ethical ap-
proval for the study was obtained from the KATH/Kwame
Nkrumah University of Science and Technology (KNUST)
Committee on Human Research, Publications and Ethics.
The data collected was entered into a Microsoft Access
database. The quantitative data were analysed using Epi
version 7.1.4. Stratified analysis based on the type of inject-
able used was conducted for all variables. The mean ages
for the women on the two different forms of injectable
contraceptives were tested for any difference using the
Kruskal-Wallis test. The association between the respective
type of injectable and specific variables were tested and all
computations were done at 95 % CI and a 5 % level of sig-
nificance. The qualitative data were analysed thematically.
Emerging themes were identified and categorised. Subse-
quently, univariate analysis of the emerging themes was
conducted using Epi Info version 7.1.4.
Results
Basic demographic information
A total 247 respondents participated in the study. The
majority of respondents (70 %) were on DMPA. The
ages of respondents ranged from 17 to 52 years with a
mean age of 32.8 ± 6.8 years and a median age of
32 years. The age-group 21-40 years accounted for the
majority of respondents. More than 50 % of respon-
dents had received only basic education (Primary or
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JSS/Middle School). Two hundred and twelve respon-
dents (85.8 %) were married (Table 1).
The mean age of respondents on DMPA was 33.8 ±
6.8 years with a range of 21 to 52 years. The mean age for
respondents on NET-EN/EV was 30.4 ± 6.23 years with an
age range of 17 to 42 years. Women on DMPA were older
than those on NET-EN/EV (p < 0.001; Kruskal-Wallis H =
11.6). Ten (2.8 %) respondents were more than 45 years of
age and they were all on DMPA. Education completed
and marital status showed no statistically significant rela-
tion to the type of injectable used (p = 0.10 and 0.60 re-
spectively). Respondents resident in rural/peri-urban did
not differ in their choice of injectable contraceptive when
compared with urban residents (OR = 1.7; 95 % CI = 0.83-
3.58; p = 0.14). Married women accounted for 87.8 % of
users of NET-EN/EV compared with 85.0 % of DMPA
(Table 2). There was no difference in the choice of inject-
able when married women were compared with single
women (OR = 0.85; 95 % CI 0.37- 1.93; p = 0.69). Com-
pared with Muslims, Christians were more likely to use
DMPA (OR = 3.26; 95 % CI 1.17- 9.13; p = 0.02).
Previous use of contraception
A total of 165 (66.8 %) of respondents were using a mod-
ern method of contraceptive for the first time. Among
those who had previously used a method of contraception,
the Combined Oral Contraceptive (COC) was the com-
monest method accounting for 42.7 %. Other methods
previously used were Norplant/Jadelle (15.9 %), IUD
(14.6 %), DMPA (12.2 %), NET-EN/EV (6.1 %) with other
methods accounting for 9.6 %. Various reasons were
assigned for the discontinuation of previous methods of
contraception. These were forgetfulness, undesirable side
effects (such as amenorrhoea, prolonged bleeding, lower
abdominal pain and weight loss).
Source of information and decision on injectable
contraceptives
The leading primary source of information on injectables
was health workers, 35.3 % for DMPA and 41.9 % for
NET-EN/EV with close relations, friends and the mass
media being the other leading sources (Table 1). The
decision to opt for an injectable contraceptive among
respondents in this study was found to have been based
on previous knowledge of the method or recommendation
from a friend or relation. A significant proportion of
respondents (72 %) also indicated that they had shared
information on injectable contraception with relations
and/or friends.
Reasons for use of injectable contraceptives
Information on effectiveness (24.7 %), recommendation
from a friend or relation (18.2 %), no associated side ef-
fects (14.2 %) and longer intervals between injections
Table 1 Demographic information on respondents
DMPA NET-EN/EV
PARAMETER Frequency % Frequency %
AGE GROUP
≤20 years 0 0 6 8.1
21-30 59 34.1 36 48.7
31-40 88 50.9 29 39.2
>40 26 15.0 3 4.0
EDUCATION COMPLETED
No formal education 16 9.3 3 4.0
Primary 37 21.4 13 17.6
JSS/Middle School 86 49.7 40 54.1
Secondary 30 17.3 12 16.2
Tertiary 4 2.3 6 8.1
MARITAL STATUS
Married 147 85.0 65 87.8
Single 24 13.9 9 12.2
Divorced 2 1.1 0 0.0
RESIDENCE
Urban 133 76.9 63 85.1
Peri-urban/Rural 40 23.1 11 14.9
ETHNICITY
Ashanti 131 75.6 53 71.6
Fanti 10 5.9 5 6.7
Ewe 6 3.5 4 5.4
Frafra 6 3.5 1 1.4
Bono 5 2.9 0 0.0
Dagomba 3 1.7 3 4.1
Others 12 6.9 8 10.8
RELIGION
Christian 165 95.3 65 87.8
Muslim 7 4.1 9 12.2
Other 1 0.6 0 0
OCCUPATION
Trading 103 59.5 39 52.7
Hairdresser 15 8.7 9 12.2
Unemployed 13 7.5 3 4
Farmer 10 5.8 0 0
Seamstress 8 4.6 8 10.8
Caterer 7 4.1 5 6.8
Teacher 3 1.7 2 2.7
Others 14 8.1 8 10.8
SOURCE OF INFORMATION ON INJECTABLES
Health worker 61 35.3 31 41.9
Relation/friend 47 27.2 22 29.7
Television 34 19.7 10 13.5
Radio 14 8 7 9.5
Others 17 9.8 4 5.4
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(12.9 %) were the leading single most important reasons
identified among respondents for opting for injectable
contraceptives (Table 3).
Forgetfulness associated with the contraceptive pills
accounted for some respondents opting for this method.
A 33-year old teacher notes that :
“With the pill, I sometimes forget but for the injection,
I always remember when it is time for my next shot”
Similar sentiments were expressed by a 25 year old
teacher who indicated that:
“I prefer injections because I do not need to take
tablets everyday as I sometimes forget”
Recommendation from relations was also identified as
one of the major reasons respondents opted for inject-
ables. Some of the responses received from participants
in this vein include:
“I chose injections because the one who introduced me
to it also uses it”
“I was encouraged by the comments a friend made
about injections”
“I decided to use it because my sister was using the
method and testified that it was good”
“My sister told me it was a more reliable method
compared with pills and I used it because I have a
child although not married”
Some respondents noted that side effects associated
with other methods as well as dislike for other methods
as reasons for opting for injectables.
“I don’t have the time to take pills and dislike
condoms as well”
“I opted for injections because I was having problems
with the IUD”
“I dislike swallowing tablets”
Lack of spousal consent and desire to be discreet
were also found to be reasons why some opted for
this method of contraception. A 26-year old appren-
tice, a 30-year old trader and another 24-year old
trader respectively highlighted their desire to keep
the use of contraception from others in the following
submissions:
“I chose injections because I am an apprentice and can
take the injection without anyone noticing”
“I opted for injectables because my husband did
not give his consent for me to take up family
planning”
“I chose injections so no one knows I am on a family
planning method”
Misinformation about another method of contracep-
tion was also identified as a reason one respondent
opted for the method. One respondent alluded to this
misinformation by other methods saying:
“I opted for injectables because I had information that
the IUD can move from the uterus”
Some respondents attributed opting for injectable contra-
ceptives to their desire to menstruate regularly. A 30 year
old woman on the combined injectable said:
“I wanted a method that will enable me menstruate
monthly”
Table 2 Injectable type by Marital Status
Marital Status Type of Injectable
DMPA (%) NET-EN/EV (%)
Married 147 (85.0) 65 (87.8)
Single 24 (13.9) 9 (12.2)
Divorced 2 (1.1) 0 (0.0)
Total 173 (100.0) 74 (100.0)
Table 3 Lead reasons given for opting for injectable
contraceptives
Reason No. %
Considered as a very effective method of Family Planning/
Contraception
61 24.7
Recommendation from a friend/relation 45 18.2
Low incidence/no associated forgetfulness (missed pills) 35 14.2
Relatively longer intervals between injections 32 12.9
Preference for injections 12 4.9
Side effects/dislike of other methods 11 4.5
No specific reason 9 3.6
Desire for regular menses (combined injectable) 8 3.2




Desire to be discreet (not wanting male partner to know) 4 1.6
Others 18 7.3
Total 247 100.0
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Satisfaction with method
The majority of respondents 225 (91.1 %) expressed sat-
isfaction with the injectable contraceptive currently be-
ing used. Among respondents on DMPA, 89.6 % were
satisfied compared with 94.6 % of respondents on NET-
EN/EV. There was no statistically significant difference
(p = 0.44) when satisfaction was compared between the
two groups (OR = 0.56; 95 % CI = 0.13- 1.79). Among
the reasons expressed were effectiveness in preventing
pregnancy (31.2 %), ability to space children (23.1 %),
peace of mind to focus on other activities (10.1 %) and
the low incidence of side effects (4.0 %). Other reported
reasons for satisfaction with the method include freedom
to decide when to get pregnant, general sense of comfort
with reproductive health state and the cessation of heavy
menstrual flow. Overall, 95.1 % of respondents in this
study indicate that they will recommend the method to
someone.
Side effects of injectable contraceptives
A total of 68 respondents (27.3 %) reported undesirable
effects (Tables 4 and 5). Multiple side effects were com-
moner in women on NET-EN/EV compared with those
on DMPA, 21.4 % and 15.0 % respectively. Approxi-
mately 55 % of side effects reported among those on
DMPA were related to menstruation (irregular menses, a
menorrhoea and intermenstrual bleeding). Among re-
spondents who reported undesirable effects, 10.8 % were
considering changing their current method.
Discussion
Some variations in the characteristics of women on vari-
ous types of contraceptives exist. Among respondents in
this study, a significant proportion were on DMPA
(70 %) compared with 30 % on NET-EN/EV and is con-
sistent with reports from the Komfo Anokye Teaching
Hospital [16, 17]. Our study also found evidence consist-
ent with data from the Ghana Demographic and Health
Surveys (DHS) that married women are more likely to
prefer injectables as a method of choice compared with
sexually active unmarried women [14]. We found that
almost 88 % of women on NET-EN/EV and 85 % of
women on DMPA were married women. Married women
being in more stable sexual relationships are more likely
to prefer relatively longer term contraceptives such as the
injectables unlike unmarried women who are less likely to
be in a regular sexual relationship hence the observed
preference for short term methods of contraception such
as male condoms [13]. The higher mean age of respon-
dents on DMPA observed may be due to the fact that
women with no desire to return to fertility are more likely
to be older and more likely to opt for DMPA because of
the relatively longer period for returning to fertility [18].
The preference for NET-EN/EV among relatively younger
women may also be due to the perceived predictable
return to fertility [19]. The variations observed can be use-
ful in informing policy on contraception in Ghana.
Changing one method of contraception to the other
may be influenced by several factors. About a third of
respondents had previously used a method of contracep-
tion before opting for injectables with the COC being
the commonest. Missing COC pills can result in method
failure requiring the use of other methods to prevent
pregnancy from occurring [20]. Women on injectables
are less likely to miss an injection compared with the
daily dose of COCs which have been associated compli-
ance challenges and failure of contraception [21–24]. In
this study, respondents were not asked about past contra-
ceptive method failures. However, even in the absence of
such method failures, the peace of mind offered by inject-
able contraceptives can be enough reason for some women
to opt for this method. The associated forgetfulness and the
subsequent need to use other methods may also underlie
the high proportion of respondents previously on COCs.
Such factors must be stressed on during counselling for
family planning in order to reduce any risk of method fail-
ure from forgetfulness.
The side effects of methods are important in determin-
ing adoption and usage [25] or change of method [11].
Various side effects have been noted for DMPA [26–29]
and NET-EN/EV [30]. Sixty-eight (27.3 %) of respondents
in this study reported at least one side effect. The low pro-
portion of respondents reporting side effects who are con-
templating change of method (10.8 %) indicates a high
Table 4 Side effects reported by respondents on NET-EN/EV
Side effect Frequency %
Multiple 6 21.4
Menorrhagia 5 17.9
Weight gain 4 14.3
Headache 3 10.7
Lower abdominal pain 2 7.1
Others 8 28.6
Total 28 100.0
Table 5 Side effects reported by respondents on DMPA
Side effect Frequency %
Irregular menses 9 22.5
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level of acceptability of injectables and is a likely factor in
the high uptake observed in Ghana. Public education on
the favourable side effect profile of injectables must be
encouraged to ensure an increase in method uptake.
Client satisfaction and the sharing of such experiences
in the final decision on the choice of contraception is a
very useful observation and can be employed in increas-
ing the contraceptive use in Ghana [13, 14]. A high pro-
portion of users expressed satisfaction with injectables
with about 72 % having already shared their pleasant ex-
periences and over 95 % expressing no reservation about
recommending them. Injectable contraceptives may con-
tinue to be the leading method of choice among Ghan-
aian women especially the married women if the current
trend should continue if highly satisfied clients are used
as ambassadors for the method.
Despite the high level of knowledge on contraception in
Ghana [13, 14] significant variations exist on knowledge
among women on the specific methods of contraception.
For example, 91 % of married women have knowledge on
injectable contraceptives compared with 80 % for the
female condom. The role of knowledge and information
in the decision to use a specific method has been demon-
strated [2, 9, 31]. Misinformation or inadequate informa-
tion on contraception can negatively impact the uptake of
a method [3, 11, 32]. Ignorance, fear and negative cultural
beliefs have been identified as factors likely to prevent
the uptake of contraceptives [8, 11].Health workers and
relations/friends formed a significant proportion of the
primary source of information on contraceptives and
they may have also influenced the decision to opt for
injectables [10, 33–35]. Health providers as Doctors
and Nurses are more likely to give accurate information
to clients and therefore less likely to misinform clients
although health workers may also impose their choices
on clients [10]. Health workers can potentially help
translate knowledge on contraception into uptake of
methods including injectables.
Although found among a few, the desire to have regu-
lar menses was found to be a reason some respondents
in our study opted for injectable contraceptive and this
is similar to findings in the United Kingdom [7]. NET-
EN/EV is associated with regular menses with DMPA
known to cause irregular menstrual bleeding and amen-
orrhoea in some cases. In Ghana, misinformation exists
on menstruation. The belief is that failure to menstruate
means a woman has dirty blood retained in her and even
bleeding for less than 3 to 7 days indicates ill health or
causes uterine fibroids [32]. These beliefs may make a
method like DMPA less acceptable, because DMPA is
generally not associated with regular menses. This study
is however unable to establish the role of these beliefs in
the desire to menstruate regularly. In contrast, respon-
dents with an extremely busy schedule and no premium
on the desire for regular menstruation [7] may find DMPA
a more attractive and acceptable option between the two
injectable contraceptives.
Ghana’s reproductive health policy is quite liberal.
Spousal consent is not a requirement for providing contra-
ception to married women [36, 37]. In our study, some
respondents, though a significantly low proportion indi-
cated the reason for opting for the method was to over-
come the barrier of spousal consent. Male partner approval
has been found to improve the uptake of injectables among
married women in the postpartum period [31]. Our study
did not consider the timing of the uptake in relation to
pregnancy and so is unable to confirm this. It is however
clear that spousal consent can influence the uptake of in-
jectables in some cases. The role of providers in this case
can also not be ruled out as providers may choose to advise
respondents on this method if clients have an expressed
desire to be discreet about contraceptive usage in order to
maintain marital harmony while meeting their reproduct-
ive health needs at the same time.
Conclusions
The preference for injectables among Ghanaian women is
influenced by a myriad of factors. Injectable contraceptives
seem well tolerated by current users with a low proportion
of current users contemplating discontinuation of the
method. The high level of acceptability means injectable
contraceptives can contribute to increasing the contracep-
tive prevalence rate in Ghana and reduce the unmet need
for Family Planning.Recent development of subcutaneous
injection of Medroxy Progesterone Acetate, to be used by
lower level cadres of providers or by self-administration
could also be useful in increasing access to contraception
in Ghana.
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